This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Canine Pyruvate Dehydrogenase E1 (PDH-E1) Alpha Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for canine pyruvate dehydrogenase E1 alpha. It can be applied to WB, IF and ICC assays of canine pyruvate dehydrogenase E1 alpha.
Specifications
Target Information
Pyruvate dehydrogenase E1 (PDH-E1) is a key component of the pyruvate dehydrogenase complex (PDC), which is a mitochondrial enzyme complex that plays a crucial role in cellular metabolism. PDH-E1 catalyzes the conversion of pyruvate, derived from glucose, into acetyl-CoA, a central molecule in the citric acid cycle (also known as the Krebs cycle or TCA cycle). This conversion is essential for aerobic respiration, as acetyl-CoA enters the citric acid cycle and is subsequently oxidized to produce ATP, the cell's primary energy currency. PDH-E1's activity is tightly regulated, responding to cellular energy needs and the availability of substrates, ensuring that glucose-derived carbon is efficiently channeled into energy production when required.
Shipping and Storage
This product is shipped with ice gel packs. Store at -20°C (up to 12 months) on receipt. Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Dahl, H. H., et al. "The human pyruvate dehydrogenase complex. Isolation of cDNA clones for the E1 alpha subunit, sequence analysis, and characterization of the mRNA." Journal of Biological Chemistry 262.15 (1987): 7398-7403.